Выбор редакции

Panel votes against label expansion for Amarin's Vascepa

  • Amarin's (AMRN) Vascepa is dealt a bitter blow as an FDA advisory committee votes 9-2 against expanding the drug's label.
  • Shares remain halted.
5 comments!
НОВОСТИ ПО ТЕМЕ